title: Role of endogenous TRPV1 agonists in a postburn pain model of partial-thickness injury.
abstract: Oxidized linoleic acid metabolites (OLAMs) are a class of endogenous transient receptor potential vanilloid 1 (TRPV1) channel agonists released on exposure of tissue to transient noxious temperatures. These lipid compounds also contribute to inflammatory and heat allodynia. Because persistent pain after a burn injury represents a significant clinical challenge for treatment, we developed an in vivo rat model of partial-thickness cutaneous thermal injury and examined whether TRPV1 and specific OLAM metabolites play a role in mediating postburn pain injury. This peripheral model of burn injury had marked thermal allodynia peaking at 24h after thermal injury, with allodynia being maintained for up to 7d. Immunohistochemical characterization of tissue taken from injury sites revealed an increase in leukocyte/macrophage infiltration that was colocalized with TRPV1-positive fibers. Using this peripheral thermal injury model, we found that pharmacological blockade of peripheral TRPV1 receptors reduced thermal allodynia by about 98%. Moreover, there was a significant increase in OLAM levels compared to naive controls in hind paw skin biopsies. Additional studies of the metabolism of [C(14)]-linoleic acid in skin biopsies revealed the role of the cytochrome P450 (CYP) system in mediating the metabolism of linoleic acid after thermal injury. Finally, we demonstrated that direct inhibition of OLAMs using OLAM antibodies and indirect inhibition using the CYP inhibitor ketoconazole significantly reduced postburn thermal allodynia. Collectively, these findings point to a novel role of the OLAMs and CYP-related enzymes in generating postburn allodynia via activation of peripheral TRPV1.
authors.affiliation: Department of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA Department of Endodontics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA Department of Biochemistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: Dustin P
authors.initials: DP
authors.lastname: Green
authors.forename: Shivani
authors.initials: S
authors.lastname: Ruparel
authors.forename: Linda
authors.initials: L
authors.lastname: Roman
authors.forename: Michael A
authors.initials: MA
authors.lastname: Henry
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Hargreaves
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D052160:Benzothiazoles / Q000627:therapeutic use; D002056:Burns / Q000150:complications* / Q000473:pathology; D002851:Chromatography, High Pressure Liquid; D006358:Hot Temperature; D006930:Hyperalgesia / Q000503:physiopathology; D007150:Immunohistochemistry; D007654:Ketoconazole / Q000627:therapeutic use; D019787:Linoleic Acid / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D009412:Nerve Fibers / Q000378:metabolism / Q000473:pathology; D020556:Neutrophil Infiltration; D010084:Oxidation-Reduction; D010146:Pain / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D010147:Pain Measurement; D011743:Pyrimidines / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000378:metabolism / Q000473:pathology; D050916:TRPV Cation Channels / Q000819:agonists* / Q000037:antagonists & inhibitors
chemical_list: D052160:Benzothiazoles; D008055:Lipids; C523409:N-(4-(6-(4-trifluoromethylphenyl)pyrimidin-4-yloxy)benzothiazol-2-yl)acetamide; D011743:Pyrimidines; D050916:TRPV Cation Channels; C493922:Trpv1 protein, rat; D019787:Linoleic Acid; D007654:Ketoconazole
keywords: Burn; Cytochrome P450; Linoleic acid; OLAM; Pain; TRPV1
references.citation: J Burn Care Res. 2007 Sep-Oct;28(5):681-90
references.pmid: 17762387
references.citation: Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18820-4
references.pmid: 19843694
references.citation: Yakugaku Zasshi. 2003 May;123(5):369-75
references.pmid: 12772594
references.citation: Biochem Int. 1990;21(3):573-9
references.pmid: 2222499
references.citation: Nature. 1997 Oct 23;389(6653):816-24
references.pmid: 9349813
references.citation: Burns. 1996 Aug;22(5):369-75
references.pmid: 8840036
references.citation: Mol Cell Biochem. 1994 Oct 26;139(2):141-8
references.pmid: 7862104
references.citation: J Burn Care Res. 2006 Sep-Oct;27(5):719-26
references.pmid: 16998406
references.citation: Pain. 2005 Jul;116(1-2):87-95
references.pmid: 15936884
references.citation: Pain. 2006 Sep;124(1-2):222-33
references.pmid: 16828970
references.citation: J Biosci. 2007 Mar;32(2):279-91
references.pmid: 17435320
references.citation: Pain. 2008 May;136(1-2):202-10
references.pmid: 18337008
references.citation: Adv Skin Wound Care. 2003 Jul-Aug;16(4):178-87; quiz 188-9
references.pmid: 12897674
references.citation: Nat Med. 1997 May;3(5):562-6
references.pmid: 9142128
references.citation: Mol Pain. 2012 Sep 24;8:73
references.pmid: 23006841
references.citation: Biochim Biophys Acta. 1993 Feb 24;1166(2-3):258-63
references.pmid: 8443245
references.citation: Biochim Biophys Acta. 1985 Oct 23;837(1):35-51
references.pmid: 2996610
references.citation: J Biol Chem. 1957 May;226(1):497-509
references.pmid: 13428781
references.citation: Burns. 2002 Dec;28(8):772-7
references.pmid: 12464476
references.citation: Neuron. 2007 Aug 2;55(3):353-64
references.pmid: 17678850
references.citation: Burns. 1991 Aug;17(4):282-7
references.pmid: 1834077
references.citation: Endocrinol Jpn. 1987 Feb;34(1):105-15
references.pmid: 3111839
references.citation: Pain. 2012 Oct;153(10):2031-2039
references.pmid: 22633978
references.citation: Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:569-72
references.pmid: 1825379
references.citation: Int J Immunopharmacol. 1990;12(2):199-205
references.pmid: 2329013
references.citation: Pain. 1988 Jan;32(1):77-88
references.pmid: 3340425
references.citation: J Clin Invest. 2010 May;120(5):1617-26
references.pmid: 20424317
references.citation: Pain. 2005 Oct;117(3):368-376
references.pmid: 16150543
references.citation: Crit Care Med. 2002 Aug;30(8):1753-61
references.pmid: 12163788
references.citation: PLoS One. 2012;7(11):e50238
references.pmid: 23189191